How AOD-9604 Works (in Brief) AOD-9604 was engineered from the C-terminal segment of human growth hormone (amino acids 177191) the portion thought to influence fat metabolism. In preclinical models, this fragment supported fat oxidation and lipid mobilization without the broader hormonal effects of full-length hGH. Because it does not activate the traditional hGH receptor, its fat-metabolism effects are considered indirect and receptor-independent. Discovery & Research Milestones Originally developed in the 1990s as a potential anti-obesity drug
Neuromodulation and Neurogenesis Preclinical studies show it promotes peripheral nerve regeneration and protects neurons from ischemic or toxic injury
Long-term effects, potential drug interactions, and effects in specific populations including pregnant women, children, and those with certain medical conditions have not been studied
Injectable BPC-157 bypasses digestion and is the form used in most of the underlying research
But if you're dragging despite sleep, dealing with unexplained weight resistance, or you've tested low for B12, it's worth the conversation
Comparison BPC-157 + TB-500 vs the larger research blends Quality Independently verified, batch by batch Tested every batch Every batch of BPC-157 + TB-500 Blend is independently analyzed by a third-party laboratory before it is released